CYCSP30

Across TCGA pan-cancer cohorts, CYCSP30 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated CYCSP30 data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher CYCSP30 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CYCSP30 expression acts as an unfavorable survival marker.

READ, LUAD, and KIRP are the cancer types where CYCSP30 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	OS	Tertile	II,III,IV	0.111	0.919	<.001	135	view →
LUAD	OS	Tertile	All	0.109	0.835	<.001	108	view →
KIRP	DFS	Tertile	IV	0.154	0.548	<.001	105	view →
LGG	OS	Tertile	All	0.423	0.813	.001	42	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	27	view →
COAD	DFS	Tertile	All	0.083	0.791	<.001	18	view →
TGCT	DFS	Tertile	All	0.441	0.841	.027	18	view →
STAD	OS	Quartile	IV	0.199	0.480	.034	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

CYCSP30–READ (OS)

Open the READ breakdown →